13G Filing: Great Point Partners and PTC Therapeutics Inc. (PTCT)

Page 3 of 10

Page 3 of 10 – SEC Filing

CUSIP
No.
69366J200
13G Page
3 of 9 Pages
1.

NAMES OF REPORTING PERSONS

Dr. Jeffrey R. Jay, M.D.

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
3. SEC USE ONLY
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING PERSON

WITH
5.

SOLE VOTING POWER

0

6.

SHARED VOTING POWER

2,160,0001

7.

SOLE DISPOSITIVE POWER

0

8.

SHARED DISPOSITIVE POWER

2,160,0001

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,160,0001

10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) o
11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.24%2

12.

TYPE OF REPORTING PERSON (See Instructions)

IN

Follow Ptc Therapeutics Inc. (NASDAQ:PTCT)

Page 3 of 10